Top Menu

FDA Denies Request from Opana ER Maker to Block Generic Forms of the Drug


The Food and Drug Administration (FDA) on Friday denied a request from the maker of the painkiller Opana ER to block generic forms of the drug. The decision came as a surprise, Reuters reports.

The drug’s manufacturer, Endo Health Solutions, argued its newer tamper-resistant formula was more difficult to abuse than the original version of the drug, and asked that the agency not approve generic forms of the earlier version. The FDA decided that since the original Opana had not been withdrawn for reasons of safety or effectiveness, generic forms of the painkiller could continue to be approved and marketed.

The FDA also said the newer Opana ER could still be abused, and might be more easily injected than the original formulation.

“We are extremely disappointed and disagree with today’s decision, and believe that the approval of non-abuse deterrent formulations of long acting opioids will contribute to a significant increase in prescription drug abuse,” Rajiv De Silva, President and Chief Executive Officer of Endo Health Solutions, said in a news release.

Last month, the FDA announced it will not approve any generic versions of the original form of OxyContin. The move is aimed at preventing prescription drug abuse. The original version of OxyContin could be crushed and then snorted or injected. The FDA also approved new labeling for a reformulated version of the drug, which will indicate it is more difficult to crush, and thus harder to abuse than the original version. OxyContin’s manufacturer, Purdue Pharma, introduced the tamper-resistant formula in 2010.

Because of the FDA’s decision about generic versions of OxyContin, many experts thought the agency would make a similar ruling about Opana ER, the article notes.

1 Response to this article

  1. Avatar of Emma
    Emma / May 13, 2013 at 2:36 pm

    Good! The only reason Endo wanted to block other companies from making the generic is purely for $$$$$$ reasons, they want to be the ONLY supplier and could care less about who suffers.
    As someone who takes Opana ER generic (being unable to take the PLASTIC brand Opana due to IBS) I know many chronic pain sufferers are beyond relieved that Impax has finally begun manufacturing the generic form of Opana ER. We cannot let chronic pain patients suffer because of addicts! People with chronic pain have no choice about being in chronic pain. Many people cannot digest the harmful products used to make these drugs abuse deterrent. I am one of the happy people who could care less about greedy big pharma who can finally get relief from the one drug that has actually worked for my chronic pain.

Leave a Reply

Please read our comment policy and guidelines before you submit a comment. Your email address will not be published. Thank you for visiting

+ 6 = thirteen

Reproduction in whole or in part of this publication is strictly prohibited without prior consent. Photographic rights remain the property of Join Together and the Partnership for Drug-Free Kids. For reproduction inquiries, please e-mail